We are live on ! Find out more
VIA

Vident Investment Advisory Portfolio holdings

AUM $2.9B
1-Year Est. Return 24.67%
This Fund
S&P 500
This Quarter Est. Return
+4.64%
1 Year Est. Return
+24.67%
3 Year Est. Return
+82.63%
5 Year Est. Return
+113.33%
10 Year Est. Return
–
AUM
$2.53B
AUM Growth
+$68.3M
Cap. Flow
+$49.5M
Cap. Flow %
1.96%
Top 10 Hldgs %
16.36%
Holding
1,009
New
121
Increased
515
Reduced
261
Closed
111

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$29.4M
2
AZTA icon
Azenta
AZTA
+$13.7M
3
FLIR
FLIR Systems, Inc. (DE) Common Stock
FLIR
+$13.2M
4
AMBA icon
Ambarella
AMBA
+$4.63M
5
TER icon
Teradyne
TER
+$3.54M

Top Sells

Rank Stock Value
1
OII icon
Oceaneering
OII
+$17.5M
2
ZBRA icon
Zebra Technologies
ZBRA
+$12.8M
3
ISRG icon
Intuitive Surgical
ISRG
+$11.2M
4
IPGP icon
IPG Photonics
IPGP
+$7.17M
5
IRBT
iRobot
IRBT
+$7.11M

Sector Composition

Rank Sector Weight
1 Technology 26.96%
2 Industrials 13.04%
3 Healthcare 11.78%
4 Consumer Discretionary 8.78%
5 Financials 6.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ACH
301
Accendra Health
ACH
$214M
$2.29M 0.09%
136,873
+14,214
+12% +$230K
CTMX icon
302
CytomX Therapeutics
CTMX
$754M
$2.28M 0.09%
99,904
+20,761
+26% +$530K
KDNY
303
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$2.28M 0.09%
65,132
+22,803
+54% +$874K
CLLS
304
Cellectis
CLLS
$285M
$2.28M 0.09%
80,527
+18,730
+30% +$558K
CSGS
305
DELISTED
CSG Systems International
CSGS
$2.28M 0.09%
55,713
+3,831
+7% +$163K
XNCR icon
306
Xencor
XNCR
$1.55B
$2.27M 0.09%
61,266
-20,105
-25% -$693K
FPRX
307
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$2.25M 0.09%
142,154
+60,608
+74% +$1.06M
HTZ
308
DELISTED
Hertz Global Holdings, Inc.
HTZ
$2.25M 0.09%
168,539
+2,528
+2% +$40.9K
ZYME icon
309
Zymeworks
ZYME
$1.67B
$2.24M 0.09%
+151,791
New +$2.35M
MAN icon
310
ManpowerGroup
MAN
$2.63B
$2.24M 0.09%
25,989
+387
+2% +$38K
T icon
311
AT&T
T
$163B
$2.24M 0.09%
92,201
+23,716
+35% +$595K
AAPL icon
312
Apple
AAPL
$4.57T
$2.23M 0.09%
48,188
-5,096
-10% -$231K
HA
313
DELISTED
Hawaiian Holdings, Inc.
HA
$2.23M 0.09%
61,882
+927
+2% +$35.7K
HST icon
314
Host Hotels & Resorts
HST
$16B
$2.22M 0.09%
105,472
+12,258
+13% +$250K
OGE icon
315
OGE Energy
OGE
$9.71B
$2.19M 0.09%
62,213
+15,996
+35% +$537K
AMKR icon
316
Amkor Technology
AMKR
$13.7B
$2.17M 0.09%
252,104
+3,780
+2% +$34.5K
EQR icon
317
Equity Residential
EQR
$25.1B
$2.15M 0.09%
33,788
+22,383
+196% +$1.39M
SAIC icon
318
Saic
SAIC
$5.35B
$2.14M 0.08%
+26,473
New +$2.25M
DAN icon
319
Dana Inc
DAN
$3.06B
$2.12M 0.08%
105,178
+1,575
+2% +$37.4K
BLUE
320
DELISTED
bluebird bio
BLUE
$2.12M 0.08%
1,042
+281
+37% +$640K
JRI icon
321
Nuveen Real Asset Income & Growth Fund
JRI
$352M
$2.1M 0.08%
129,948
+3,690
+3% +$60.2K
AKAM icon
322
Akamai
AKAM
$15.9B
$2.08M 0.08%
28,411
-1,490
-5% -$112K
ED icon
323
Consolidated Edison
ED
$39.9B
$2.07M 0.08%
26,507
+1,930
+8% +$147K
ATRA icon
324
Atara Biotherapeutics
ATRA
$76.1M
$2.02M 0.08%
2,197
-2,515
-53% -$2.7M
KLIC icon
325
Kulicke & Soffa
KLIC
$4.78B
$1.96M 0.08%
82,274
+1,363
+2% +$32.3K
11 12
13
14 15

Similar funds

EST
EA Series Trust Havertown, Pennsylvania $2.84B AUM
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
AWS
AJ Wealth Strategies New York $2.07B AUM 10.86% 1-Year Est. Return
WI
Winder Investment Singapore $4.4B AUM 8.87% 1-Year Est. Return
JP
Jana Partners New York $1.34B AUM 4.95% 1-Year Est. Return
VCM
Vigilant Capital Management Portland, Maine $1.34B AUM 15.33% 1-Year Est. Return
FCB
First Command Bank Fort Worth, Texas $1.06B AUM 10.74% 1-Year Est. Return
FCFS
First Command Financial Services Fort Worth, Texas $1.06B AUM 10.74% 1-Year Est. Return

Vident Investment Advisory's Q2 2018 Portfolio in Review

As of Q2 2018, Vident Investment Advisory held 1,009 positions worth $2.53B, up 2.8% from $2.46B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Vident Investment Advisory's Q2 2018 filing shows 121 new, 515 increased, 261 reduced and 111 closed positions. Its largest new stake was Arcus Biosciences: 156,139 shares worth $1.91M. The largest sale was Oceaneering, an estimated $17.5M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 28% a quarter earlier, followed by Industrials and Healthcare.

  • Vident Investment Advisory's largest Q2 2018 buy was Arcus Biosciences: 156,139 shares worth $1.91M.
  • Vident Investment Advisory added most to State Street SPDR S&P 500 ETF Trust in Q2 2018, an estimated $29.4M increase.
  • Vident Investment Advisory's biggest Q2 2018 reduction was Oceaneering, cutting an estimated $17.5M.
  • Vident Investment Advisory fully exited FIRST TRUST HIGH INCOME LONG/SHORT FUND in Q2 2018, selling an estimated $5.5M.
  • Vident Investment Advisory's ten largest holdings make up 16% of its $2.53B portfolio in Q2 2018.
  • Vident Investment Advisory opened 121 new positions and closed 111 in Q2 2018.
  • Vident Investment Advisory's portfolio value rose 2.8% quarter-over-quarter to $2.53B.

Based on Vident Investment Advisory's 13F filing for Q2 2018, filed 14 Aug 2018.